PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Schänzer, A.* ; Achleitner, M.* ; Trümbach, D. ; Hubert, L.* ; Munnich, A.* ; Ahlemeyer, B.* ; AlAbdulrahim, M.M.* ; Greif, P.A.* ; Vosberg, S.* ; Hummer, B.* ; Feichtinger, R.G.* ; Mayr, J.A.* ; Wortmann, S.B. ; Aichner, H.* ; Rudnik-Schöneborn, S.* ; Ruiz, A.* ; Gabau, E.* ; Sánchez, J.P.* ; Ellard, S.* ; Homfray, T.* ; Stals, K.L.* ; Wurst, W. ; Neubauer, B.A.* ; Acker, T.* ; Bohlander, S.K.* ; Asensio, C.* ; Besmond, C.* ; Alkuraya, F.S.* ; AlSayed, M.D.* ; Hahn, A.* ; Weber, A.*

Mutations in HID1 cause syndromic infantile encephalopathy and hypopituitarism.

Ann. Neurol. 90, 143-158 (2021)
Postprint DOI PMC
Open Access Hybrid
OBJECTIVE: Precursors of peptide hormones undergo posttranslational modifications within the trans-Golgi network (TGN). Dysfunction of proteins involved at different steps of this process cause several complex syndromes affecting the central nervous system (CNS). We aimed to clarify the genetic cause in a group of patients characterized by hypopituitarism in combination with brain atrophy, thin corpus callosum, severe developmental delay, visual impairment, and epilepsy. METHODS: Whole exome sequencing (WES) was performed in seven individuals of six unrelated families with these features. Postmortem histopathological and HID1 expression analysis of brain tissue and pituitary gland were conducted in one patient. Functional consequences of the homozygous HID1 variant p.R433W were investigated by Seahorse XF Assay in fibroblasts of two patients. RESULTS: Bi-allelic variants in the gene HID1 domain-containing protein 1 (HID1) were identified in all patients. Post mortem examination confirmed cerebral atrophy with enlarged lateral ventricles. Markedly reduced expression of pituitary hormones was found in pituitary gland tissue. Colocalization of HID1 protein with the TGN was not altered in fibroblasts of patients compared to controls, while the extracellular acidification rate (ECAR) upon stimulation with potassium chloride was significantly reduced in patient fibroblasts compared to controls. INTERPRETATION: Our findings indicate that mutations in HID1 cause an early infantile encephalopathy with hypopituitarism as the leading presentation, and expand the list of syndromic CNS diseases caused by interference of TGN function.
Impact Factor
Scopus SNIP
Altmetric
10.422
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Melchior-clausen Dysplasia; Gene; Landscape; Alignment; Encodes; Server
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 0364-5134
e-ISSN 1531-8249
Zeitschrift Annals of Neurology
Quellenangaben Band: 90, Heft: 1, Seiten: 143-158 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Metabolism and Cell Death (MCD)
Institute of Human Genetics (IHG)
Institute of Developmental Genetics (IDG)
POF Topic(s) 30203 - Molecular Targets and Therapies
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
30204 - Cell Programming and Repair
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-506900-001
G-500700-001
G-500500-001
G-500500-009
Förderungen Blood Cancer New Zealand
NCI
NHGRI
NHLBI
NIDA
NIMH
NINDS
AMPro project, 'Aging and Metabolic Programming', through the Initiative and Network Fund of the Helmholtz Association
German Federal Ministry of Education and Research (BMBF)
Initiative and Network Fund of the Helmholtz Association
ERA PerMed project PerMim (Austrian Science Fund FWF)
ERA E-RARE-3 project GENOMIT (Austrian Science Fund FWF)
German Science Foundation Collaborative Research Centre (CRC) 870
Family of Marijana Kumerich
Projekt DEAL
Joint Project HIT-Tau (High Throughput Approaches for the Individualized Therapy of Tau-Related Diseases TP2)
Common Fund of the Office of the Director of the National Institutes of Health
DOI 10.1002/ana.26127
WOS ID WOS:000658060100001
Scopus ID 85107188174
PubMed ID 33999436
Erfassungsdatum 2021-05-28
[➜Korrektur melden]